ഓൾമെസാർടാൻ മിഡോക്സോമിൽ
ഓൾമെസാർടാൻ മിഡോക്സോമിൽ ഉയർന്ന രക്തസമ്മർദ്ദത്തെ ചികിത്സിക്കാനുള്ള ഔഷധമാണ്. 1995ൽ ഡൈച്ചി സാക്യോ കോർപരേഷൻ ആണ് വികസിപ്പിച്ചത്.
Systematic (IUPAC) name | |
---|---|
(5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylate | |
Clinical data | |
Trade names | Olmecip. |
AHFS/Drugs.com | monograph |
MedlinePlus | a603006 |
Pregnancy category |
|
Routes of administration | Oral |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 26% |
Metabolism | Hepatic (cannot be removed by hemodialysis) |
Biological half-life | 13 hours |
Excretion | Renal 40%, biliary 60% |
Identifiers | |
CAS Number | 144689-63-4 |
ATC code | C09CA08 (WHO) C09DA08 (with diuretics) C09DB02 (with amlodipine) |
PubChem | CID 130881 |
IUPHAR/BPS | 591 |
DrugBank | DB00275 |
ChemSpider | 115748 |
UNII | 6M97XTV3HD |
KEGG | D01204 |
ChEMBL | CHEMBL1516 |
Chemical data | |
Formula | C29H30N6O6 |
Molar mass | 558.585 g/mol |
| |
| |
(what is this?) (verify) |